文献速递头颈部肿瘤放疗

头颈鳞癌GTV到高危CTV外扩从10mm减至6mm可显著降低放化疗毒性与疗效相当

Reduction of GTV to high-risk CTV radiation margin in head and neck squamous cell carcinoma significantly reduced acute and late radiation-related toxicity with comparable outcomes.
PubMed 文献 · Radiother Oncol · 2021-07-24

6mm组急性3级毒性、3级黏膜炎、≥2级吞咽困难、喂养管依赖及晚期2级口干均显著低于10mm组,2年局部区域控制、无病生存和总生存两组无显著差异。

要点

  • GTV到高危CTV外扩从10mm减至6mm显著降低急性3级毒性(48% vs 67%)。
  • 6mm组急性3级黏膜炎、≥2级吞咽困难及喂养管依赖均显著减少。
  • 晚期2级口干6mm组显著低于10mm组(32% vs 50%)。

核心结论

  • 将GTV到高危CTV外扩从10mm减至6mm可显著降低放化疗相关毒性的发生率和严重程度,且不降低局部区域控制与生存。

研究设计与样本

  • 所有患者接受容积调强弧形放疗(VMAT)并每日锥形束CT图像引导。

主要发现

  • 6mm组与10mm组总体急性3级毒性分别为48%与67%(p<0.01)。
  • 6mm组与10mm组急性3级黏膜炎分别为18%与34%(p<0.01),≥2级吞咽困难分别为67%与85%(p<0.01)。
  • 6mm组与10mm组治疗结束时喂养管依赖分别为25%与37%(p=0.02),3个月时为12%与25%(p<0.01),6个月时为6%与15%(p=0.01)。
  • 6mm组与10mm组晚期2级口干分别为32%与50%(p<0.01)。
  • 6mm组与10mm组2年局部区域控制分别为78.7%与73.1%,无病生存分别为70.6%与61.4%,总生存分别为83.2%与74.4%(p>0.05)。

临床怎么用

  • 在VMAT联合每日CBCT图像引导下,可考虑将头颈鳞癌GTV到高危CTV外扩从10mm减至6mm以降低毒性。
  • 该策略需结合图像引导精度和中心经验个体化实施,并关注急性和晚期毒性及肿瘤学结局。

局限性

  • 为单中心回顾性研究,两组为先后连续队列而非同期随机对照,可能存在时间偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: We aim to retrospectively investigate whether reducing GTV to high-risk CTV margin will significantly reduce acute and late toxicity without jeopardizing outcome in head-and-neck squamous cell carcinoma (HNSCC) treated with definitive (chemo)radiation. MATERIALS AND METHODS: Between April 2015 and April 2019, 155 consecutive patients were treated with GTV to high-risk CTV margin of 10 mm and subsequently another 155 patients with 6 mm margin. The CTV-PTV margin was 3 mm for both groups. All patients were treated with volumetric-modulated arc therapy with daily image-guidance using cone-beam CT. End points of the study were acute and late toxicity and oncologic outcomes. RESULTS: Overall acute grade 3 toxicity was significantly lower in 6 mm, compared to 10 mm group (48% vs. 67%, respectively, p < 0.01). The same was true for acute grade 3 mucositis (18% vs. 34%, p < 0.01) and grade ≥ 2 dysphagia (67% vs. 85%, p < 0.01). Also feeding tube-dependency at the end of treatment (25% vs. 37%, p = 0.02), at 3 months (12% and 25%, p < 0.01), and at 6 months (6% and 15%, p = 0.01) was significantly less in 6 mm group. The incidence of late grade 2 xerostomia was also significantly lower in the 6 mm group (32% vs. 50%, p < 0.01). The 2-year rates of loco-regional control, disease-free and overall survival were 78.7% vs. 73.1%, 70.6% vs. 61.4%, and 83.2% vs. 74.4% (p > 0.05, all). CONCLUSION: The first study reporting on reduction of GTV to high-risk CTV margin from 10 to 6 mm showed significant reduction of the incidence and severity of radiation-related toxicity without reducing local-regional control and survival.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Al-Mamgani A, Kessels R, Navran A, et al. Reduction of GTV to high-risk CTV radiation margin in head and neck squamous cell carcinoma significantly reduced acute and late radiation-related toxicity with comparable outcomes. Radiother Oncol. 2021. PMID: 34311003. doi:10.1016/j.radonc.2021.07.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。